Immune mechanisms in acquired demyelinating neuropathies: Lessons from animal models

Neuromuscular Disorders

Volumn 12, Issue 4, 2002, Pages 405-414

  Mäurer, Mathias ^a   Toyka, Klaus V ^a   Gold, Ralf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Animal models; Demyelinating neuropathies; Immune mechanisms

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR IMMUNITY; DEMYELINATING NEUROPATHY; DISEASE COURSE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNITY; IMMUNOTHERAPY; INFLAMMATION; MACROPHAGE; NEURITIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; NEUROIMMUNOMODULATION;

EID: 0036223666     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(01)00302-9     Document Type: Article

References (85)

1. Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies
2. Animal models for autoimmune demyelinating disorders of the nervous system
3. Eighty three years of the Guillain-Barré syndrome: Clinical and immunopathologic aspects, current and future treatments
4. Molecular genetics and biology of inherited peripheral neuropathies: A fast-moving field
5. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in P0
6. Mechanisms of immune regulation in the peripheral nervous system
7. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: Induction of experimental allergic neuritis (EAN) by PO protein-specific T cell lines
8. Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones
9. Induction of experimental autoimmune neuritis with peripheral myelin protein-22
10. Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat
11. Candidate autoantigens in multiple sclerosis
12. Permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo
13. Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines
14. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease
15. New minimum length requirement for a T cell epitope for experimental allergic neuritis
16. Reduced susceptibility of T cell-deficient rats to induction of experimental allergic neuritis
17. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta
18. Suppression of P2-T cell line-mediated experimental autoimmune neuritis by interleukin-2 receptor targeted monoclonal antibody ART 18
19. Morphological study on EAN mediated by T cell line specific for bovine P2 protein in Lewis rats
20. Immune mechanisms in inflammatory polyneuropathy
21. The effects of mast cell degranulation on blood-nerve barrier permeability and nerve conduction in vivo
22. Nonneural-specific T. lymphocytes can orchestrate inflammatory peripheral neuropathy
23. Changes in lymphocyte subsets during the course of experimental allergic neuritis
24. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: A tale of smart bombs and the infantry
25. T-cell apoptosis in inflammatory brain lesions: Destruction of T cells does not depend on antigen recognition
26. In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat
27. Glucocorticosteroids modulate antigen-induced T-cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ
28. The role of macrophages in immune-mediated damage to the peripheral nervous system
29. Macrophages but not Schwann cells express Ia antigen in experimental autoimmune neuritis
30. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes
31. Synergistic effect of IFN-gamma and TNF-α on expression of immune molecules and antigen presentation by Schwann cells
32. Human autoimmune neuropathies
33. T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barre syndrome
34. Immune-mediated demyelination
35. Electron microscope observations on demyelination and remyelination in experimental allergic neuritis. I. Demyelination
36. The effect of suppression of macrophage activity on the development of experimental allergic neuritis
37. Mechanism of demyelination in experimental allergic neuritis. Electron microscopic studies
38. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis
39. And astrocytes: Stimulation of the cyclooxygenase pathway of arachidonic acid metabolism
40. The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line
41. Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase
42. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system
43. Complement regulatory molecules on human myelin and glial cells: Differential expression affects the deposition of activated complement proteins
44. Lymphocyte homing and homeostasis
45. The role of integrins in immune-mediated diseases of the nervous system
46. The role of the very late antigen-4 (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) in the pathogenesis of experimental autoimmune neuritis (EAN) of the Lewis rat
47. Macrophages and endothelial cells express intercellular adhesion molecule-1 in immune-mediated demyelination but not in Wallerian degeneration of the rat peripheral nervous system
48. Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1
49. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1
50. Role of the leukocyte-adhesion molecule L-selectin in experimental autoimmune encephalomyelitis
51. Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis
52. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis
53. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside
54. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody
55. Production of prostanoids by Lewis rat Schwann cells in vitro
56. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro
57. Neurosteroids: Pregnenolone in human sciatic nerves
58. Lipocortin-1 (annexin-1) suppresses activation of autoimmune T cell lines in the Lewis rat
59. The expression of CD59 in normal human nervous tissue
60. T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms
61. The Fas death factor
62. Immune (dys)regulation in multiple sclerosis: Role of the CD95/CD95 ligand system
63. Regulation of Fas and FasL expression on Schwann cells
64. Intravenous glucocorticoid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat
65. Schwann cell undergoes apoptosis during experimental allergic neuritis (EAN)
66. Schwann cell apoptosis in experimental autoimmune neuritis and the functinal role of TNF
67. Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat
68. Antigen therapy eliminates T-cell inflammation by apoptosis: Effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2
69. Blockade of signalling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T-cell apoptosis in experimental autoimmune neuritis
70. Role of TNF-α in high-dose antigen therapy in experimental autoimmune neuritis: Inhibition of TNF-α by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis
71. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy
72. Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP)
73. Acute inflammatory neuropathy in Charcot-Marie-Tooth disease
74. Prednisone-responsive hereditary motor and sensory neuropathy
75. Phenotypic variation of a new P0 mutation in genetically identical twins
76. Animal models for inherited peripheral neuropathies: Chances to find treatment strategies?
77. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance
78. RAG-1-deficient mice have no mature B and T lymphocytes
79. Experimental allergic neuritis in the Lewis rat
80. Phagocytosis of myelin in demyelinative disease: A review
81. Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in the mouse
82. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses
83. Matrix metalloproteinase expression during experimental autoimmune neuritis
84. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: Evidence for functionally distinct forms of CD28